The global Recombinant Coagulation Factor IX market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report is a detailed and comprehensive analysis for global Recombinant Coagulation Factor IX market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Coagulation Factor IX market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Coagulation Factor IX market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Coagulation Factor IX market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Coagulation Factor IX market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Coagulation Factor IX
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Coagulation Factor IX market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Coagulation Factor IX market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
500 IU
1000 IU
Other
Market segment by Application
Adult
Children
Major players covered
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Coagulation Factor IX product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Coagulation Factor IX, with price, sales quantity, revenue, and global market share of Recombinant Coagulation Factor IX from 2020 to 2025.
Chapter 3, the Recombinant Coagulation Factor IX competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Coagulation Factor IX breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Coagulation Factor IX market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Coagulation Factor IX.
Chapter 14 and 15, to describe Recombinant Coagulation Factor IX sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Coagulation Factor IX Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 500 IU
1.3.3 1000 IU
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Coagulation Factor IX Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Adult
1.4.3 Children
1.5 Global Recombinant Coagulation Factor IX Market Size & Forecast
1.5.1 Global Recombinant Coagulation Factor IX Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Recombinant Coagulation Factor IX Sales Quantity (2020-2031)
1.5.3 Global Recombinant Coagulation Factor IX Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Recombinant Coagulation Factor IX Product and Services
2.1.4 Pfizer Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pfizer Recent Developments/Updates
2.2 Rebinyn
2.2.1 Rebinyn Details
2.2.2 Rebinyn Major Business
2.2.3 Rebinyn Recombinant Coagulation Factor IX Product and Services
2.2.4 Rebinyn Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Rebinyn Recent Developments/Updates
2.3 CSL Behring
2.3.1 CSL Behring Details
2.3.2 CSL Behring Major Business
2.3.3 CSL Behring Recombinant Coagulation Factor IX Product and Services
2.3.4 CSL Behring Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 CSL Behring Recent Developments/Updates
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Recombinant Coagulation Factor IX Product and Services
2.4.4 Takeda Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takeda Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Recombinant Coagulation Factor IX Product and Services
2.5.4 Sanofi Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sanofi Recent Developments/Updates
2.6 Aptevo Bio Therapeutics
2.6.1 Aptevo Bio Therapeutics Details
2.6.2 Aptevo Bio Therapeutics Major Business
2.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product and Services
2.6.4 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Aptevo Bio Therapeutics Recent Developments/Updates
3 Competitive Environment: Recombinant Coagulation Factor IX by Manufacturer
3.1 Global Recombinant Coagulation Factor IX Sales Quantity by Manufacturer (2020-2025)
3.2 Global Recombinant Coagulation Factor IX Revenue by Manufacturer (2020-2025)
3.3 Global Recombinant Coagulation Factor IX Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Recombinant Coagulation Factor IX by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Recombinant Coagulation Factor IX Manufacturer Market Share in 2024
3.4.3 Top 6 Recombinant Coagulation Factor IX Manufacturer Market Share in 2024
3.5 Recombinant Coagulation Factor IX Market: Overall Company Footprint Analysis
3.5.1 Recombinant Coagulation Factor IX Market: Region Footprint
3.5.2 Recombinant Coagulation Factor IX Market: Company Product Type Footprint
3.5.3 Recombinant Coagulation Factor IX Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Recombinant Coagulation Factor IX Market Size by Region
4.1.1 Global Recombinant Coagulation Factor IX Sales Quantity by Region (2020-2031)
4.1.2 Global Recombinant Coagulation Factor IX Consumption Value by Region (2020-2031)
4.1.3 Global Recombinant Coagulation Factor IX Average Price by Region (2020-2031)
4.2 North America Recombinant Coagulation Factor IX Consumption Value (2020-2031)
4.3 Europe Recombinant Coagulation Factor IX Consumption Value (2020-2031)
4.4 Asia-Pacific Recombinant Coagulation Factor IX Consumption Value (2020-2031)
4.5 South America Recombinant Coagulation Factor IX Consumption Value (2020-2031)
4.6 Middle East & Africa Recombinant Coagulation Factor IX Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
5.2 Global Recombinant Coagulation Factor IX Consumption Value by Type (2020-2031)
5.3 Global Recombinant Coagulation Factor IX Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
6.2 Global Recombinant Coagulation Factor IX Consumption Value by Application (2020-2031)
6.3 Global Recombinant Coagulation Factor IX Average Price by Application (2020-2031)
7 North America
7.1 North America Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
7.2 North America Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
7.3 North America Recombinant Coagulation Factor IX Market Size by Country
7.3.1 North America Recombinant Coagulation Factor IX Sales Quantity by Country (2020-2031)
7.3.2 North America Recombinant Coagulation Factor IX Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
8.2 Europe Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
8.3 Europe Recombinant Coagulation Factor IX Market Size by Country
8.3.1 Europe Recombinant Coagulation Factor IX Sales Quantity by Country (2020-2031)
8.3.2 Europe Recombinant Coagulation Factor IX Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Recombinant Coagulation Factor IX Market Size by Region
9.3.1 Asia-Pacific Recombinant Coagulation Factor IX Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Recombinant Coagulation Factor IX Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
10.2 South America Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
10.3 South America Recombinant Coagulation Factor IX Market Size by Country
10.3.1 South America Recombinant Coagulation Factor IX Sales Quantity by Country (2020-2031)
10.3.2 South America Recombinant Coagulation Factor IX Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Recombinant Coagulation Factor IX Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Recombinant Coagulation Factor IX Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Recombinant Coagulation Factor IX Market Size by Country
11.3.1 Middle East & Africa Recombinant Coagulation Factor IX Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Recombinant Coagulation Factor IX Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Recombinant Coagulation Factor IX Market Drivers
12.2 Recombinant Coagulation Factor IX Market Restraints
12.3 Recombinant Coagulation Factor IX Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Recombinant Coagulation Factor IX and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Coagulation Factor IX
13.3 Recombinant Coagulation Factor IX Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Coagulation Factor IX Typical Distributors
14.3 Recombinant Coagulation Factor IX Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
听
听
*If Applicable.
